Pfizer's strong pipeline of drugs and its fortress balance sheet make it an attractive investment at cheap valuation multiples. Click to read why PFE is a Buy.
Access to COVID-19 vaccines looks a little different for many Washingtonians, as federal guidance continues to shift and state recommendations try to keep up.
The journey toward an RSV vaccine for children has been wrought with tragedy and setbacks. But six decades after scientists embarked on that path, they are nearing the finish line ...
But -- finally -- Pfizer is getting into the obesity drug game. This past week, the company announced it will acquire Metsera, a clinical-stage biopharmaceutical firm that is developing several ...
WSYR Syracuse on MSN
Interview: Director of Upstate Global Health breaks down latest vaccine guidance
Dr. Stephen Thomas, director of Upstate Global Health, discussed the recent changes to the childhood vaccine schedule, the confusion surrounding COVID vaccine recommendations, and the potential impact ...
A robust pipeline of experimental and recently launched drugs could make the next several years exciting ones to be a Pfizer shareholder.
6don MSN
Where Will Pfizer Be in 5 Years?
In later stages of the pandemic, sales of coronavirus products flagged. To add to this bad news, investors focused on upcoming patent expirations for some of Pfizer's key products. As a result, Pfizer ...
We received hundreds of queries about efficacy, safety, cost and access.
American Indian and Alaska Native infants experience the highest rates of RSV-related hospitalization in the U.S., but a breakthrough immunization is helping to close the gap ...
15hon MSN
An allergy-free future? mRNA vaccine prevents dangerous reactions in mice exposed to allergens
A new mRNA vaccine stopped allergens from causing dangerous immune reactions and life-threatening inflammation in mice, according to researchers from the Perelman School of Medicine at the University ...
News-Medical.Net on MSN
New mRNA vaccine stops allergens from causing life-threatening inflammation in mice
A new mRNA vaccine stopped allergens from causing dangerous immune reactions and life-threatening inflammation in mice, according to researchers from the Perelman School of Medicine at the University ...
The updated formula for Moderna’s COVID-19 vaccine generates a 16-fold increase in antibodies neutralize the intended SARS-CoV-2 variant.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback